Mitochondrial Integrity Is Critical in Right Heart Failure Development
暂无分享,去创建一个
[1] G. Du,et al. Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension. , 2022, European journal of pharmacology.
[2] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.
[3] H. Milting,et al. Right Heart Failure in Mice Upon Pressure Overload Is Promoted by Mitochondrial Oxidative Stress , 2022, JACC. Basic to translational science.
[4] V. Agrawal,et al. l‐Carnitine therapy improves right heart dysfunction through Cpt1‐dependent fatty acid oxidation , 2022, Pulmonary circulation.
[5] P. Orchard,et al. N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy , 2021, Biomedicines.
[6] M. Mehrpooya,et al. Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure , 2021, Irish Journal of Medical Science (1971 -).
[7] T. Thenappan,et al. With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension , 2021, JACC. Basic to translational science.
[8] H. Mannherz,et al. The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts , 2021, Antioxidants.
[9] S. Nekolla,et al. Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension , 2021, Journal of Cardiovascular Magnetic Resonance.
[10] Ingrid S. Lan,et al. Transcriptomic and Functional Analyses of Mitochondrial Dysfunction in Pressure Overload‐Induced Right Ventricular Failure , 2021, Journal of the American Heart Association.
[11] Taylor P Williams,et al. Effect of Mitochondrial Antioxidant (Mito-TEMPO) on Burn Injury-Induced Cardiac Dysfunction. , 2021, Journal of the American College of Surgeons.
[12] N. Trayanova,et al. Hydrogen peroxide diffusion and scavenging shapes mitochondrial network instability and failure by sensitizing ROS-induced ROS release , 2020, Scientific Reports.
[13] G. Hansmann,et al. Emerging therapies for right ventricular dysfunction and failure. , 2020, Cardiovascular diagnosis and therapy.
[14] V. Agrawal,et al. Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension , 2020, Journal of the American Heart Association.
[15] G. Hansmann,et al. Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism. , 2020, Cardiovascular diagnosis and therapy.
[16] V. Hjortdal,et al. Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure , 2020, Scientific Reports.
[17] G. Hansmann,et al. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension , 2020, Heart.
[18] G. Fonarow,et al. Effects of Elamipretide on Left Ventricular Function in Patients with Heart Failure with Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. , 2020, Journal of cardiac failure.
[19] G. Hansmann,et al. Activation of The Metabolic Master Regulator PPARγ - A Potential PIOneering Therapy for Pulmonary Arterial Hypertension. , 2020, American journal of respiratory cell and molecular biology.
[20] J. Newman,et al. BMPR2 dysfunction impairs insulin signaling and glucose homeostasis in cardiomyocytes. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[21] R. Metzger,et al. Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of PA de-banding. , 2019, Cardiovascular research.
[22] K. Casali,et al. Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension , 2019, Molecular and Cellular Biochemistry.
[23] Yunliang Zang,et al. Exploring Impaired SERCA Pump-Caused Alternation Occurrence in Ischemia , 2019, Comput. Math. Methods Medicine.
[24] Resham Bhattacharya,et al. Hydrogen sulfide signaling in mitochondria and disease , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] M. Eghbali,et al. Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension , 2019, Front. Physiol..
[26] N. Isern,et al. Metabolic Response to Stress by the Immature Right Ventricle Exposed to Chronic Pressure Overload , 2019, Journal of the American Heart Association.
[27] B. Ghanim,et al. Disconnect between Fibrotic Response and Right Ventricular Dysfunction. , 2019, American journal of respiratory and critical care medicine.
[28] A. Hickey,et al. Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment , 2019, PloS one.
[29] Yuichiro J. Suzuki,et al. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension , 2019, Journal of the American Heart Association.
[30] S. Archer,et al. Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities , 2019, Front. Cardiovasc. Med..
[31] S. Prabhu,et al. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice , 2019, Redox biology.
[32] R. Schulz,et al. Review on Chamber-Specific Differences in Right and Left Heart Reactive Oxygen Species Handling , 2018, Front. Physiol..
[33] V. Agrawal,et al. Adverse physiologic effects of Western diet on right ventricular structure and function: role of lipid accumulation and metabolic therapy , 2018, Pulmonary circulation.
[34] S. Archer,et al. Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension , 2018, Front. Physiol..
[35] C. Maack,et al. Metabolic remodelling in heart failure , 2018, Nature Reviews Cardiology.
[36] B. O’Rourke,et al. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure , 2018, Circulation research.
[37] G. Hansmann,et al. PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation , 2018, Science Translational Medicine.
[38] W. Seeger,et al. Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension , 2018, European Respiratory Journal.
[39] M. Murphy,et al. MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload , 2018, Free radical biology & medicine.
[40] C. Tschöpe,et al. Right ventricular strain in heart failure: Clinical perspective. , 2017, Archives of cardiovascular diseases.
[41] Yuichiro J Suzuki,et al. Oxidative profiling of the failing right heart in rats with pulmonary hypertension , 2017, PloS one.
[42] Arantxa González,et al. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome , 2017, Journal of hypertension.
[43] R. Tian,et al. Metabolism in cardiomyopathy: every substrate matters , 2017, Cardiovascular research.
[44] S. Archer,et al. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension , 2017, Journal of Molecular Medicine.
[45] C. Nediani,et al. Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target , 2016, Oxidative medicine and cellular longevity.
[46] D. Stewart,et al. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. , 2016, European heart journal cardiovascular Imaging.
[47] J. Mascherbauer,et al. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study , 2016, Circulation. Cardiovascular imaging.
[48] W. Fang,et al. Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study. , 2016, European heart journal cardiovascular Imaging.
[49] R. Rodenburg,et al. Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure. , 2016, Cardiovascular research.
[50] C. Ottenheijm,et al. Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension , 2016, Circulation. Heart failure.
[51] Cheuk-Kwan Sun,et al. Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice , 2016, Acta Pharmacologica Sinica.
[52] R. Gerszten,et al. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension , 2016, Circulation.
[53] J. Bian,et al. Hydrogen Sulfide and Cellular Redox Homeostasis , 2016, Oxidative medicine and cellular longevity.
[54] P. Ferdinandy,et al. Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense. , 2015, Antioxidants & redox signaling.
[55] D. Bernstein,et al. Molecular Mechanisms of Right Ventricular Failure , 2015, Circulation.
[56] W. Fang,et al. The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension , 2015, Clinical nuclear medicine.
[57] P. Lipp,et al. Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure. , 2015, Cell metabolism.
[58] R. Wüst,et al. Decreased creatine kinase is linked to diastolic dysfunction in rats with right heart failure induced by pulmonary artery hypertension , 2015, Journal of molecular and cellular cardiology.
[59] B. Guida,et al. NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis , 2015, Front. Physiol..
[60] H. Krum,et al. A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients , 2015, Cardiovascular therapeutics.
[61] A. Briasoulis,et al. Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis , 2015, Heart.
[62] C. Zuurbier,et al. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure? , 2015, Respiratory Research.
[63] S. Gupte,et al. Increased Reactive Oxygen Species, Metabolic Maladaptation, and Autophagy Contribute to Pulmonary Arterial Hypertension–Induced Ventricular Hypertrophy and Diastolic Heart Failure , 2014, Hypertension.
[64] M. Humbert,et al. N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats , 2014, Respiratory Research.
[65] S. Matoba,et al. Oxidative Post-Translational Modifications Develop LONP1 Dysfunction in Pressure Overload Heart Failure , 2014, Circulation. Heart failure.
[66] H. Szeto,et al. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis , 2014, British journal of pharmacology.
[67] H. Szeto. First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics , 2014, British journal of pharmacology.
[68] M. Friedberg,et al. Right Versus Left Ventricular Failure: Differences, Similarities, and Interactions , 2014, Circulation.
[69] L. Gleaves,et al. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.
[70] H. Champion,et al. Mitochondria in Cardiovascular Physiology and Disease Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension : indications for a seminal role for mitochondrial Nox 4 , 2013 .
[71] A. Trafford,et al. Sarcoplasmic Reticulum Ca-ATPase and Heart Failure 20 Years Later , 2013, Circulation research.
[72] H. Szeto,et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. , 2013, Journal of the American Society of Nephrology : JASN.
[73] A. Alzoubi,et al. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. , 2013, American journal of physiology. Heart and circulatory physiology.
[74] J. Sadoshima,et al. Thioredoxin 1 Is Essential for Sodium Sulfide–Mediated Cardioprotection in the Setting of Heart Failure , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[75] D. Kass,et al. Nitric oxide synthases in heart failure. , 2013, Antioxidants & redox signaling.
[76] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[77] J. Dou,et al. Theoretical investigation of the mechanism of heart failure using a canine ventricular cell model: especially the role of up-regulated CaMKII and SR Ca(2+) leak. , 2013, Journal of molecular and cellular cardiology.
[78] S. Steinberg. Oxidative Stress and Sarcomeric Proteins , 2013, Circulation research.
[79] J. Bigbee,et al. Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension , 2013, Circulation. Heart failure.
[80] M. MacCoss,et al. Global Proteomics and Pathway Analysis of Pressure-Overload–Induced Heart Failure and Its Attenuation by Mitochondrial-Targeted Peptides , 2012, Circulation. Heart failure.
[81] Andres I Rodriguez,et al. Chronic hypoxia induces right heart failure in caveolin-1-/- mice. , 2012, American journal of physiology. Heart and circulatory physiology.
[82] R. Balaban,et al. Homogenous protein programming in the mammalian left and right ventricle free walls. , 2011, Physiological genomics.
[83] N. Westerhof,et al. Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen Utilization , 2011, Circulation. Heart failure.
[84] A. Einstein,et al. PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension , 2011, Circulation. Cardiovascular imaging.
[85] P. D. del Nido,et al. Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease , 2011, Circulation. Heart failure.
[86] N. Ozdemir,et al. Increased Right Ventricular Glucose Metabolism in Patients With Pulmonary Arterial Hypertension , 2011, Clinical nuclear medicine.
[87] Roberta Menabò,et al. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. , 2011, Biochimica et biophysica acta.
[88] F. Di Lisa,et al. Oxidation of myofibrillar proteins in human heart failure. , 2011, Journal of the American College of Cardiology.
[89] Benedikt Westermann,et al. Mitochondrial fusion and fission in cell life and death , 2010, Nature Reviews Molecular Cell Biology.
[90] Marina Bayeva,et al. Mitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins , 2010, Current hypertension reports.
[91] S. Cortassa,et al. Redox-optimized ROS balance: a unifying hypothesis. , 2010, Biochimica et biophysica acta.
[92] J. Rydström,et al. Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. , 2010, Biochimica et biophysica acta.
[93] G. Schuler,et al. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Con , 2010, Journal of the American College of Cardiology.
[94] W. Guo,et al. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection , 2010, Bioscience reports.
[95] W. Paulus,et al. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. , 2010, American journal of physiology. Heart and circulatory physiology.
[96] F. Stillitano,et al. Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure. , 2010, Biochimica et biophysica acta.
[97] T. Gasser,et al. Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach , 2009, Nucleic acids research.
[98] C. Long,et al. Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure , 2009, Circulation.
[99] Kohtaro Abe,et al. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. , 2009, Chest.
[100] Can Ince,et al. In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique. , 2008, Biophysical journal.
[101] J. Dyck,et al. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. , 2008, The Journal of thoracic and cardiovascular surgery.
[102] J. Strahler,et al. Quantifying changes in the thiol redox proteome upon oxidative stress in vivo , 2008, Proceedings of the National Academy of Sciences.
[103] M. J. Wagner,et al. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. , 2007, Cardiovascular research.
[104] M. J. Faber,et al. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. , 2007, Journal of molecular and cellular cardiology.
[105] M. Sharpley,et al. Interaction of the Mitochondria-targeted Antioxidant MitoQ with Phospholipid Bilayers and Ubiquinone Oxidoreductases* , 2007, Journal of Biological Chemistry.
[106] A. Mugelli,et al. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. , 2007, Journal of molecular and cellular cardiology.
[107] Can Ince,et al. Mitochondrial PO2 measured by delayed fluorescence of endogenous protoporphyrin IX , 2006, Nature Methods.
[108] S. Mital,et al. Failure of Right Ventricular Adaptation in Children With Tetralogy of Fallot , 2006, Circulation.
[109] F. Ashcroft,et al. Deletion of Nicotinamide Nucleotide Transhydrogenase , 2006, Diabetes.
[110] C. Epstein,et al. Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase. , 2006, Human molecular genetics.
[111] H. M. Cochemé,et al. Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing , 2005, Mechanisms of Ageing and Development.
[112] J. Tune,et al. Mechanisms of Oxygen Demand/Supply Balance in the Right Ventricle , 2005, Experimental biology and medicine.
[113] H. Szeto,et al. Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury* , 2004, Journal of Biological Chemistry.
[114] Liang-Jun Yan. Analysis of Oxidative Modification of Proteins , 2000, Current protocols in protein science.
[115] K. Yagi,et al. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. , 1999, Biochemical and biophysical research communications.
[116] J. Schaper,et al. Ultrastructural Morphometric Analysis of Myocardium from Dogs, Rats, Hamsters, Mice, and from Human Hearts , 1985, Circulation research.
[117] A. A. Armoundas,et al. Functional Implications of Cardiac Mitochondria Clustering. , 2017, Advances in experimental medicine and biology.
[118] M. Loebe,et al. Differential Mitochondrial Function in Remodeled Right and Nonremodeled Left Ventricles in Pulmonary Hypertension. , 2016, Journal of cardiac failure.
[119] S. Archer,et al. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate , 2012, Journal of Molecular Medicine.
[120] S. Archer,et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle , 2011, Journal of Molecular Medicine.
[121] I. Haber,et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle , 2009, Journal of Molecular Medicine.
[122] Robin A. J. Smith,et al. Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity. , 2009, Free radical biology & medicine.
[123] K. Tanonaka,et al. Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats. , 2009, Journal of pharmacological sciences.
[124] X. Leverve,et al. Subcellular heterogeneity of mitochondrial function and dysfunction: Evidence obtained by confocal imaging , 2004, Molecular and Cellular Biochemistry.
[125] N. van Zandwijk. N‐Acetylcysteine (NAC) and glutathione (GSH): Antioxidant and chemopreventive properties, with special reference to lung cancer , 1995, Journal of cellular biochemistry. Supplement.